Cite
"In-silico exploration of cyanobacterial bioactive compounds for managing diabetes: Targeting alpha-amylase and beta-glucosidase".
MLA
Khanam, Afreen, et al. “‘In-Silico Exploration of Cyanobacterial Bioactive Compounds for Managing Diabetes: Targeting Alpha-Amylase and Beta-Glucosidase.’” Intelligent Pharmacy, vol. 1, no. 4, Dec. 2023, pp. 232–43. EBSCOhost, https://doi.org/10.1016/j.ipha.2023.08.003.
APA
Khanam, A., Kavita, K. M., Sharma, R. K., Farooqui, A., Ahmad, S., Kumar, P., & Husain, A. (2023). “In-silico exploration of cyanobacterial bioactive compounds for managing diabetes: Targeting alpha-amylase and beta-glucosidase.” Intelligent Pharmacy, 1(4), 232–243. https://doi.org/10.1016/j.ipha.2023.08.003
Chicago
Khanam, Afreen, K. M. Kavita, Rakesh Kumar Sharma, Alvina Farooqui, Saheem Ahmad, Pankaj Kumar, and Arbab Husain. 2023. “‘In-Silico Exploration of Cyanobacterial Bioactive Compounds for Managing Diabetes: Targeting Alpha-Amylase and Beta-Glucosidase.’” Intelligent Pharmacy 1 (4): 232–43. doi:10.1016/j.ipha.2023.08.003.